Natural killer T cells in lipoprotein metabolism and atherosclerosis

被引:28
作者
Getz, Godfrey S. [1 ]
VanderLaan, Paul A. [1 ]
Reardon, Catherine A. [1 ]
机构
[1] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
关键词
Atherosclerosis; CD1d; NKT cells; NKT CELLS; ANTIGEN PRESENTATION; IMMUNE-RESPONSE; INVARIANT; ACTIVATION; DEFICIENCY; SYSTEM; MICE; ISOGLOBOTRIHEXOSYLCERAMIDE; INTESTINE;
D O I
10.1160/TH11-05-0336
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cells of both the innate and adaptive immune system participate in the development of atherosclerosis, a chronic inflammatory disorder of medium and large arteries. Natural killer T (NKT) cells express surface markers characteristic of natural killer cells and conventional T cells and bridge the innate and adaptive immune systems. The development and activation of NKT cells is dependent upon CD1d, a MHC-class I-type molecule that presents lipids, especially glycolipids to the T cell receptors on NKT cells. There are two classes of NKT cells; invariant NKT cells that express a semi-invariant T cell receptor and variant NKT cells. This review summarises studies in murine models in which the effect of the activation, overexpression or deletion of NKT cells or only invariant NKT cells on atherosclerosis has been examined.
引用
收藏
页码:814 / 819
页数:6
相关论文
共 50 条
[1]   Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells [J].
Allan, Lenka L. ;
Hoefl, Katrin ;
Zheng, Dong-Jun ;
Chung, Brian K. ;
Kozak, Frederick K. ;
Tan, Rusung ;
van den Elzen, Peter .
BLOOD, 2009, 114 (12) :2411-2416
[2]   Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions [J].
Aslanian, AM ;
Chapman, HA ;
Charo, IF .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (03) :628-632
[3]   CD1 antigen presentation: how it works [J].
Barral, Duarte C. ;
Brenner, Michael B. .
NATURE REVIEWS IMMUNOLOGY, 2007, 7 (12) :929-941
[4]   Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1T cells [J].
Bendelac, A ;
Hunziker, RD ;
Lantz, O .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) :1285-1293
[5]   The biology of NKT cells [J].
Bendelac, Albert ;
Savage, Paul B. ;
Teyton, Luc .
ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 :297-336
[6]   Presumed guilty: natural killer T cell defects and human disease [J].
Berzins, Stuart P. ;
Smyth, Mark J. ;
Baxter, Alan G. .
NATURE REVIEWS IMMUNOLOGY, 2011, 11 (02) :131-142
[7]   The Contrasting Roles of NKT Cells in Tumor Immunity [J].
Berzofsky, Jay A. ;
Terabe, Masaki .
CURRENT MOLECULAR MEDICINE, 2009, 9 (06) :667-672
[8]   Natural IgM Antibodies Against Oxidation-Specific Epitopes [J].
Binder, Christoph J. .
JOURNAL OF CLINICAL IMMUNOLOGY, 2010, 30 :S56-S60
[9]   Co-accumulation of dendritic cells and natural killer T cells within rupture-prone regions in human atherosclerotic plaques [J].
Bobryshev, YV ;
Lord, RSA .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2005, 53 (06) :781-785
[10]   Regulatory B cells as inhibitors of immune responses and inflammation [J].
Bouaziz, Jean-David ;
Yanaba, Koichi ;
Tedder, Thomas F. .
IMMUNOLOGICAL REVIEWS, 2008, 224 :201-214